These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 23698598)

  • 21. Early Elevation of Complement Factor Ba Is a Predictive Biomarker for Transplant-Associated Thrombotic Microangiopathy.
    Okamura H; Nakamae H; Shindo T; Ohtani K; Hidaka Y; Ohtsuka Y; Makuuchi Y; Kuno M; Takakuwa T; Harada N; Nishimoto M; Nakashima Y; Koh H; Hirose A; Nakamae M; Wakamiya N; Hino M; Inoue N
    Front Immunol; 2021; 12():695037. PubMed ID: 34326846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glomerular C4d deposits can mark structural capillary wall remodelling in thrombotic microangiopathy and transplant glomerulopathy: C4d beyond active antibody-mediated injury: a retrospective study.
    Gasim AH; Chua JS; Wolterbeek R; Schmitz J; Weimer E; Singh HK; Nickeleit V
    Transpl Int; 2017 May; 30(5):519-532. PubMed ID: 28207978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased Body Mass Index Augments Endothelial Injury and Clinical Outcomes after Hematopoietic Stem Cell Transplantation.
    Koo J; Ziady AG; Reynaud D; Abdullah S; Luebbering N; Kahn S; Langenberg L; Strecker L; Lake K; Dandoy CE; Lane A; Myers KC; Sabulski A; Good S; Nalapareddy K; Solomon M; Siefert ME; Skala E; Jodele S; Davies SM
    Transplant Cell Ther; 2023 Nov; 29(11):704.e1-704.e8. PubMed ID: 37625594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
    Jodele S; Dandoy CE; Myers KC; El-Bietar J; Nelson A; Wallace G; Laskin BL
    Transfus Apher Sci; 2016 Apr; 54(2):181-90. PubMed ID: 27156964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The significance of C4d staining with minimal histologic abnormalities.
    Haas M
    Curr Opin Organ Transplant; 2010 Feb; 15(1):21-7. PubMed ID: 19907328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy.
    Jodele S; Licht C; Goebel J; Dixon BP; Zhang K; Sivakumaran TA; Davies SM; Pluthero FG; Lu L; Laskin BL
    Blood; 2013 Sep; 122(12):2003-7. PubMed ID: 23814021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics of pediatric allogeneic hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA): a retrospective single-center analysis.
    Luo L; Xiong H; Chen Z; Yang L; Sun M; Lu W; Tao F; Wang Z; Li J; Li Z; Tang S
    Clin Transl Oncol; 2023 Aug; 25(8):2451-2461. PubMed ID: 36973479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research.
    Schoettler ML; Carreras E; Cho B; Dandoy CE; Ho VT; Jodele S; Moissev I; Sanchez-Ortega I; Srivastava A; Atsuta Y; Carpenter P; Koreth J; Kroger N; Ljungman P; Page K; Popat U; Shaw BE; Sureda A; Soiffer R; Vasu S
    Transplant Cell Ther; 2023 Mar; 29(3):151-163. PubMed ID: 36442770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary Manifestations and Vascular Changes in Pediatric Transplantation-Associated Thrombotic Microangiopathy.
    Schoettler ML; Saldana BD; Berkenkamp L; Chonat S; Watkins B; Rotz SJ; Simons D; Graf E; Rossi C; Cheng J; Hammers YA; Rytting H; Williams KM
    Transplant Cell Ther; 2023 Jan; 29(1):45.e1-45.e8. PubMed ID: 36202334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic Plasma Exchange does not Improve Renal Function in Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy: An Institutional Experience.
    Sartain S; Shubert S; Wu MF; Srivaths P; Teruya J; Krance R; Martinez C
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):157-162. PubMed ID: 30144562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Case of the nephrotic syndrome in bone marrow transplantation recipient, histologically showing overlapped glomerular lesions of thrombotic microangiopathy and membranous nephropathy.
    Masuzawa N; Nishimura A; Kitani T; Tamagaki K; Sugitani M; Nagoshi H; Kuroda J; Konishi E
    Pathol Int; 2017 Dec; 67(12):620-625. PubMed ID: 28940837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haptoglobin degradation product as a novel serum biomarker for hematopoietic stem cell transplant-associated thrombotic microangiopathy.
    Schuh MP; Bennett MR; Lane A; Jodele S; Laskin BL; Devarajan P
    Pediatr Nephrol; 2019 May; 34(5):865-871. PubMed ID: 30569313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab.
    Jodele S; Dandoy CE; Lane A; Laskin BL; Teusink-Cross A; Myers KC; Wallace G; Nelson A; Bleesing J; Chima RS; Hirsch R; Ryan TD; Benoit S; Mizuno K; Warren M; Davies SM
    Blood; 2020 Mar; 135(13):1049-1057. PubMed ID: 31932840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombotic Microangiopathy After Hematopoietic Stem Cell and Solid Organ Transplantation: A Review for Intensive Care Physicians.
    Nusrat S; Davis H; MacDougall K; George JN; Nakamura R; Borogovac A
    J Intensive Care Med; 2024 May; 39(5):406-419. PubMed ID: 37990516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of peritubular capillary, glomerular, and arteriolar C4d staining patterns in paraffin sections of early kidney transplant biopsies.
    Kikić Z; Regele H; Nordmeyer V; Wahrmann M; Kletzmayr J; Bartel G; Böhmig GA
    Transplantation; 2011 Feb; 91(4):440-6. PubMed ID: 21127459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk and prognostic factors of transplantation-associated thrombotic microangiopathy in allogeneic haematopoietic stem cell transplantation: a nested case control study.
    Ye Y; Zheng W; Wang J; Hu Y; Luo Y; Tan Y; Shi J; Zhang M; Huang H
    Hematol Oncol; 2017 Dec; 35(4):821-827. PubMed ID: 27245857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis.
    Mejia-Vilet JM; Gómez-Ruiz IA; Cruz C; Méndez-Pérez RA; Comunidad-Bonilla RA; Uribe-Uribe NO; Nuñez-Alvarez CA; Morales-Buenrostro LE
    Clin Rheumatol; 2021 Jun; 40(6):2233-2242. PubMed ID: 33170371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic Utility of Complement Immunohistochemical Studies in Post-Stem Cell Transplant Intestinal Thrombotic Microangiopathy: Case Report.
    Rossoff JE; Schneiderman J; Chaudhury S; Arva NC
    J Pediatr Hematol Oncol; 2017 May; 39(4):282-286. PubMed ID: 28060108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury.
    Böhmig GA; Exner M; Habicht A; Schillinger M; Lang U; Kletzmayr J; Säemann MD; Hörl WH; Watschinger B; Regele H
    J Am Soc Nephrol; 2002 Apr; 13(4):1091-1099. PubMed ID: 11912271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. De novo thrombotic microangiopathy in renal allograft biopsies-role of antibody-mediated rejection.
    Satoskar AA; Pelletier R; Adams P; Nadasdy GM; Brodsky S; Pesavento T; Henry M; Nadasdy T
    Am J Transplant; 2010 Aug; 10(8):1804-11. PubMed ID: 20659088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.